StreetInsider.com News Articles

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Fri, 17 Jul 2026 16:08:00 -0400

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Erasca, Inc. who were adversely affected if they purchased the Company's shares between January 14, 2025 and April 26, 2026, both dates inclusive (the "Class Period"). This action is pending in the United States District Court for

Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Fri, 17 Jul 2026 16:08:00 -0400

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

Erasca, Inc. (Nasdaq: ERAS) closed a public offering of 36,142,857 shares of common stock at $17.50 per share, generating approximately $632.5 million in gross proceeds before underwriting discounts, commissions, and other expenses, according to a press release.

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

The company said it intends to use the net proceeds, along with existing cash, cash equivalents, and marketable securities, to fund research and development of its product candidates and other development programs, as well as for working capital and general corporate

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca closes $632.5M public offering of common stock

Wed, 15 Jul 2026 16:02:00 -0400

The offering included 4,714,285 shares sold through the full exercise of the underwriters' option to purchase additional shares. All shares were sold by Erasca.

Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares